502 related articles for article (PubMed ID: 24895528)
1. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
4. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.
Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT
FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792
[TBL] [Abstract][Full Text] [Related]
6. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
[TBL] [Abstract][Full Text] [Related]
9. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms.
Zhuo C; Xin J; Huang W; Zhang D; Yan X; Li R; Li H; Lan J; Lin L; Li L; Wang X; Liu L; Wang Y; Li X; Mao Y; Chen H; Wu S; Yang X; Jiang W
Toxicology; 2023 Aug; 494():153597. PubMed ID: 37499777
[TBL] [Abstract][Full Text] [Related]
10. TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy.
Guo Z; Tang N; Liu FY; Yang Z; Ma SQ; An P; Wu HM; Fan D; Tang QZ
J Cell Mol Med; 2020 Sep; 24(18):10913-10923. PubMed ID: 33140921
[TBL] [Abstract][Full Text] [Related]
11. β-LAPachone ameliorates doxorubicin-induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice.
Nazari Soltan Ahmad S; Sanajou D; Kalantary-Charvadeh A; Hosseini V; Roshangar L; Khojastehfard M; Haiaty S; Mesgari-Abbasi M
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):364-373. PubMed ID: 31630478
[TBL] [Abstract][Full Text] [Related]
12. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of TRIM16 mitigates doxorubicin-induced cardiotoxicity by modulating TAK1 and YAP/Nrf2 pathways in mice.
Guo X; Liu M; Han B; Zheng Y; Zhang K; Bao G; Gao C; Shi H; Sun Q; Zhao Z
Biochem Pharmacol; 2024 Feb; 220():116009. PubMed ID: 38154547
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin.
Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X
Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936
[TBL] [Abstract][Full Text] [Related]
15. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Zhang WB; Lai X; Guo XF
Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
[TBL] [Abstract][Full Text] [Related]
16. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
Wu YP; Zhang S; Xin YF; Gu LQ; Xu XZ; Zhang CD; You ZQ
Phytomedicine; 2021 Jul; 88():153597. PubMed ID: 34111614
[TBL] [Abstract][Full Text] [Related]
17. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane protects the heart from doxorubicin-induced toxicity.
Singh P; Sharma R; McElhanon K; Allen CD; Megyesi JK; Beneš H; Singh SP
Free Radic Biol Med; 2015 Sep; 86():90-101. PubMed ID: 26025579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
